Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.5800
0.00 (0.00%)
Feb 6, 2026, 4:00 PM EST
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 23 employees as of September 30, 2025. The number of employees decreased by 6 or -20.69% compared to the same quarter last year.
Employees
23
Change
-6
Growth
-20.69%
Revenue / Employee
n/a
Profits / Employee
-$471,565
Market Cap
6.37M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Orgenesis | 146 |
| NKGen Biotech | 26 |
| Mosaic ImmunoEngineering | 8 |
| Bioxytran | 3 |
| Synlogic | 1 |
Brainstorm Cell Therapeutics News
- 3 months ago - BrainStorm Cell Therapeutics GAAP EPS of -$0.91, revenue of $7M - Seeking Alpha
- 3 months ago - BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 6 months ago - Brainstorm Cell Therapeutics outlines readiness for Phase IIIb ALS trial as funding and regulatory developments shape next steps - Seeking Alpha
- 6 months ago - Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - BrainStorm Cell Therapeutics GAAP EPS of -$0.77 - Seeking Alpha
- 6 months ago - BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 6 months ago - BrainStorm Cell Therapeutics Q2 2025 Earnings Preview - Seeking Alpha